A Double-Blind Placebo-Controlled Study of Lamotrigine Monotherapy in Outpatients With Bipolar I Depression
The DOI matches its Crossref record.
Abstract
BACKGROUND: More treatment options for bipolar depression are needed. Currently available antidepressants may increase the risk of mania and rapid cycling, and mood stabilizers appear to be less effective in treating depression than mania. Preliminary data suggest that lamotrigine, an established antiepileptic drug, may be effective for both the depression and mania associated with bipolar disorder. This is the first controlled multicenter study evaluating lamotrigine monotherapy in the treatment of bipolar I depression. METHODS: Outpatients with bipolar I disorder experiencing a major depressive episode (DSM-IV, N = 195) received lamotrigine (50 or 200 mg/day) or placebo as monotherapy for 7 weeks. Psychiatric evaluations, including the Hamilton Rating Scale for Depression (HAM-D), the Montgomery-Asberg Depression Rating Scale (MADRS), Mania Rating Scale, and the Clinical Global Impressions scale for Severity (CGI-S) and Improvement (CGI-I) were completed at each weekly visit. RESULTS: Lamotrigine 200 mg/day demonstrated significant antidepressant efficacy on the 17-item HAM-D, HAM-D Item 1, MADRS, CGI-S, and CGI-I compared with placebo. Improvements were seen as early as week 3. Lamotrigine 50 mg/day also demonstrated efficacy compared with placebo on several measures. The proportions of patients exhibiting a response on CGI-I were 51%, 41%, and 26% for lamotrigine 200 mg/day, lamotrigine 50 mg/day, and placebo groups, respectively. Adverse events and other safety results were similar across treatment groups, except for a higher rate of headache in the lamotrigine groups. CONCLUSION: Lamotrigine monotherapy is an effective and well-tolerated treatment for bipolar depression.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“while clinical experience and the results of many studies suggest that response to mood stabilizers and antipsychotics is similar in BDII and BDI, there are enough exceptions to suggest this should not be taken for granted.248, 405, 431”
Citations
Cites
Still being checked.
Cited by
Items 301–400 of 1,000
Glutamate and psychiatric disorders
Tsapakis, E.-M., & Travis, M. J. (2002) · Advances in Psychiatric Treatment · doi:10.1192/apt.8.3.189 · Cited by 51
Parikh, S. V., LeBlanc, S. R., & Ovanessian, M. M. (2010) · The Canadian Journal of Psychiatry · doi:10.1177/070674371005500304 · Cited by 43
Psychiatric uses of antiepileptic treatments
Boylan, L. S., Devinsky, O., Barry, J. J., & Ketter, T. A. (2002) · Epilepsy & Behavior · doi:10.1016/s1525-5069(02)00501-7 · Cited by 43
Lamotrigine and antiepileptic drugs as mood stabilizers in bipolar disorder
Muzina, D. J., Elhaj, O., Gajwani, P., Gao, K., & Calabrese, J. R. (2005) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.2005.00523.x · Cited by 49
Self-citationEffect of Lamotrigine on Mood and Cognition in Patients Receiving Chronic Exogenous Corticosteroids
Brown, E. S., Frol, A. B., Bobadilla, L., Nejtek, V. A., Perantie, D. C., & Dhillon, H. (2003) · Psychosomatics · doi:10.1176/appi.psy.44.3.204 · Cited by 46
Efficacy of antimanic treatments in mixed states
McIntyre, R. S., & Yoon, J. (2012) · Bipolar Disorders · doi:10.1111/j.1399-5618.2012.00990.x · Cited by 42
Rating Scales in Bipolar Disorder
Sajatovic, M., Chen, P., & Young, R. C. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-405170-6.00009-9 · Cited by 57
Non-epilepsy uses of antiepilepsy drugs.
Zaremba, P., Białek, M., Błaszczyk, B., Cioczek, P., & Czuczwar, S. J. (2006) · PubMed · Cited by 42
Women and bipolar disorder across the life span.
Sit, D. K. Y. (2004) · PubMed · Cited by 58
Maintenance therapies for classic and other forms of bipolar disorder
Bowden, C. L., Lecrubier, Y., Bauer, M. S., Goodwin, G. M., Greil, W., Sachs, G. S., & von Knorring, L. (2000) · Journal of Affective Disorders · doi:10.1016/s0165-0327(00)00179-8 · Cited by 45
Self-citationVan Der Loos, M. L. M., Mulder, P., Hartong, E. G. T. M., Blom, M. B. J., Vergouwen, A. C., Van Noorden, M. S., Timmermans, M. A., Vieta, E., Nolen, W. A., & for the LamLit Study Group (2010) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.2009.01537.x · Cited by 41
Antidepressant Properties of Anticonvulsant Drugs for Bipolar Disorder
Ernst, C. L., & Goldberg, J. F. (2003) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-200304000-00011 · Cited by 44
ECNP Consensus Meeting March 2000 Nice
Montgomery, D. (2001) · European Neuropsychopharmacology · doi:10.1016/s0924-977x(00)00140-1 · Cited by 44
Brunoni, A. R., Tadini, L., & Fregni, F. (2010) · PLoS ONE · doi:10.1371/journal.pone.0009479 · Cited by 39
Safety profile of lamotrigine in overdose
Alabi, A., Todd, A., Husband, A., & Reilly, J. G. (2016) · Therapeutic Advances in Psychopharmacology · doi:10.1177/2045125316656707 · Cited by 40
Rachid, F. (2017) · Journal of Psychiatric Practice · doi:10.1097/pra.0000000000000219 · Cited by 41
Traumatic Brain Injury and Suicidal Behavior: A Review
Wadhawan, A., Stiller, J. W., Potocki, E., Okusaga, O. O., Dagdag, A., Lowry, C. A., Benros, M. E., & Postolache, T. T. (2019) · Journal of Alzheimer s Disease · doi:10.3233/jad-181055 · Cited by 41
Burden of Illness in Bipolar Depression
Manning, J. S. (2005) · The Primary Care Companion For CNS Disorders · doi:10.4088/pcc.v07n0601 · Cited by 45
Walden, J., Schaerer, L., Schloesser, S., & Grunze, H. (2000) · Bipolar Disorders · doi:10.1034/j.1399-5618.2000.020408.x · Cited by 40
Goldberg, J. F., & Nassir Ghaemi, S. (2005) · Bipolar Disorders · doi:10.1111/j.1399-5618.2005.00251.x · Cited by 40
Kemp, D. E., Gao, K., Fein, E. B., Chan, P. K., Conroy, C., Obral, S., Ganocy, S. J., & Calabrese, J. R. (2012) · Bipolar Disorders · doi:10.1111/bdi.12013 · Cited by 39
“A modicum of evidence also suggests that lamotrigine is efficacious for acute bipolar depression (15), including as an add-on treatment for patients non-responsive to lithium (16).”
BackgroundSelf-citationLamotrigine in the treatment of bipolar disorder
Bowden, C. L. (2002) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.3.10.1513 · Cited by 42
Self-citationPsychopharmacology of pediatric bipolar disorder: a review
Smarty, S., & Findling, R. L. (2006) · Psychopharmacology · doi:10.1007/s00213-006-0569-y · Cited by 41
Anticonvulsants in Bipolar Disorder
Bowden, C. L., & Karren, N. U. (2006) · Australian & New Zealand Journal of Psychiatry · doi:10.1080/j.1440-1614.2006.01815.x · Cited by 42
Self-citationAbelaira, H. M., Réus, G. Z., Ribeiro, K. F., Steckert, A. V., Mina, F., Rosa, D. V., Santana, C. V., Romano‐Silva, M. A., Dal‐Pizzol, F., & Quevedo, J. (2013) · Neuroscience Research · doi:10.1016/j.neures.2013.02.002 · Cited by 38
Efficacy and tolerability of treatments for bipolar depression
Vázquez, G. H., Holtzman, J. N., Tondo, L., & Baldessarini, R. J. (2015) · Journal of Affective Disorders · doi:10.1016/j.jad.2015.05.016 · Cited by 42
Lamotrigine-associated rash: to rechallenge or not to rechallenge?
Lorberg, B. A., Youssef, N. A., & Bhagwagar, Z. (2008) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145708009504 · Cited by 39
Chronic Administration of Lamotrigine Downregulates COX-2 mRNA and Protein in Rat Frontal Cortex
Lee, H., Ertley, R. N., Rapoport, S. I., Bazinet, R. P., & Rao, J. S. (2007) · Neurochemical Research · doi:10.1007/s11064-007-9526-3 · Cited by 44
Cookson, J., Keck, P. E., Ketter, T. A., & Macfadden, W. (2007) · International Clinical Psychopharmacology · doi:10.1097/yic.0b013e3280119dfb · Cited by 39
Mood stabilization in the treatment of bipolar disorder: focus on quetiapine
Vieta, E. (2005) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.689 · Cited by 44
Antiepileptic drugs in psychiatry—focus on randomized controlled trial
Muzina, D. J., El-Sayegh, S., & Calabrese, J. R. (2002) · Epilepsy Research · doi:10.1016/s0920-1211(02)00080-3 · Cited by 39
Self-citationWhat is to be done? Controversies in the Diagnosis and Treatment of Manic-Depressive Illness
Ghaemi, N., Sachs, G. S., & Goodwin, F. K. (2000) · The World Journal of Biological Psychiatry · doi:10.3109/15622970009150569 · Cited by 36
Self-citationAntiepileptic Drugs in Mood‐Disordered Patients
Gajwani, P., Forsthoff, A., Muzina, D. J., Amann, B. L., Gao, K., Elhaj, O., Calabrese, J. R., & Grunze, H. (2005) · Epilepsia · doi:10.1111/j.1528-1167.2005.463008.x · Cited by 38
Self-citationPharmacotherapy of bipolar depression: An update
Thase, M. E. (2006) · Current Psychiatry Reports · doi:10.1007/s11920-006-0055-6 · Cited by 42
Li, N., He, X., Qi, X., Zhang, Y., & He, S. (2010) · Journal of Psychopharmacology · doi:10.1177/0269881109359102 · Cited by 37
Antidepressant Drugs: Indications and Guidelines for Use in Epilepsy
Schmitz, B. (2002) · Epilepsia · doi:10.1046/j.1528-1157.2002.043s2014.x · Cited by 36
Treating Bipolar Illness: Focus on Treatment Algorithms and Management of the Sleep-Wake Cycle
Leibenluft, E., & Suppes, T. M. (1999) · American Journal of Psychiatry · doi:10.1176/ajp.156.12.1976 · Cited by 38
Improvement in depression associated with partial epilepsy in patients treated with lamotrigine
Kalogjera-Sackellares, D., & Sackellares, J. C. (2002) · Epilepsy & Behavior · doi:10.1016/s1525-5050(02)00528-0 · Cited by 37
Pregnenolone for cognition and mood in dual diagnosis patients
Osuji, I. J., Vera‐Bolanos, E., Carmody, T. J., & Brown, E. S. (2010) · Psychiatry Research · doi:10.1016/j.psychres.2009.09.006 · Cited by 37
Abelaira, H. M., Réus, G. Z., Ribeiro, K. F., Zappellini, G., Cipriano, A. L., Scaini, G., STRECK, E. L., & Quevedo, J. (2012) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2012.01.019 · Cited by 40
Lamotrigine in patients with epilepsy and comorbid depressive symptoms
Fakhoury, T. A., Barry, J. J., Miller, J. M., Hammer, A. E., & Vuong, A. (2006) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2006.11.003 · Cited by 38
Avoiding Drug-Induced Switching in Patients with Bipolar Depression
Henry, C., & Demotes‐Mainard, J. (2003) · Drug Safety · doi:10.2165/00002018-200326050-00003 · Cited by 39
Emerging Options in the Treatment of Bipolar Disorders
Berk, M., Segal, J., Janet, L., & Vorster, M. (2001) · Drugs · doi:10.2165/00003495-200161100-00004 · Cited by 38
Ghaemi, S. N. (2001) · Bipolar Disorders · doi:10.1034/j.1399-5618.2001.030304.x · Cited by 37
An open case series on the utility of tiagabine as an augmentation in refractory bipolar outpatients
Schaffer, L. C., Schaffer, C. B., & Howe, J. (2002) · Journal of Affective Disorders · doi:10.1016/s0165-0327(01)00407-4 · Cited by 41
Novel treatments for bipolar disorder
Bowden, C. L. (2001) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.10.4.661 · Cited by 36
Self-citationPharmacotherapy of Bipolar Disorder in Children and Adolescents: Recent Progress
Pfeifer, J. C., Kowatch, R. A., & DelBello, M. P. (2010) · CNS Drugs · doi:10.2165/11533110-000000000-00000 · Cited by 41
Weisler, R. H., Cutler, A. J., Ballenger, J. C., Post, R. M., & Ketter, T. A. (2006) · CNS Spectrums · doi:10.1017/s1092852900014917 · Cited by 37
Rapid-cycling bipolar disorder
Calabrese, J. R., RAPPORT, D. J., Findling, R. L., Shelton, M. D., & Kimmel, S. E. (2000) · Springer eBooks · doi:10.1007/0-306-47521-9_4 · Cited by 36
Self-citationNaturalistic Long-term Use of Methylphenidate in Bipolar Disorder
Lydon, E., & El-Mallakh, R. S. (2006) · Journal of Clinical Psychopharmacology · doi:10.1097/01.jcp.0000236655.62920.dc · Cited by 34
Is Your Depressed Patient Bipolar?
Kaye, N. (2005) · The Journal of the American Board of Family Medicine · doi:10.3122/jabfm.18.4.271 · Cited by 37
The armamentarium of treatments for bipolar disorder: a review of the literature
Cousins, D. A., & Young, A. H. (2006) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145706007413 · Cited by 35
Acute and maintenance treatment with mood stabilizers
Bowden, C. L. (2003) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145703003535 · Cited by 34
Self-citationRevised Korean medication algorithm for bipolar disorder
Jon, D., Bahk, W., Yoon, B. H., Shin, Y. C., Cho, H. S., Lee, E. M., Ha, K., Kim, W. K., Chung, S. K., Seo, J. S., et al. (2009) · The World Journal of Biological Psychiatry · doi:10.1080/15622970802144865 · Cited by 35
Atypical Antipsychotics for the Treatment of Bipolar Disorder: More Shadows than Lights
Gentile, S. (2007) · CNS Drugs · doi:10.2165/00023210-200721050-00002 · Cited by 37
Lamotrigine-associated anticonvulsant hypersensitivity syndrome in bipolar disorder
Chang, C.-C., Shiah, I., Yeh, C., Wang, T., & Chang, H. (2006) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2005.11.033 · Cited by 34
Keck, P. E., & McElroy, S. L. (2002) · Journal of Affective Disorders · doi:10.1016/s0165-0327(01)00355-x · Cited by 40
The effects of antiepileptic drugs on cognitive functional magnetic resonance imaging.
Beltramini, G. C., Cendes, F., & Yasuda, C. L. (2015) · Europe PMC (PubMed Central) · doi:10.3978/j.issn.2223-4292.2015.01.04 · Cited by 32
Long-Term Use of Pramipexole in Bipolar Depression: A Naturalistic Retrospective Chart Review
El‐Mallakh, R. S., Penagaluri, P., Kantamneni, A., Gao, Y., & Roberts, R. J. (2010) · Psychiatric Quarterly · doi:10.1007/s11126-010-9130-6 · Cited by 34
Mood Stabilizers of First and Second Generation
RYBAKOWSKI, J. K. (2023) · Brain Sciences · doi:10.3390/brainsci13050741 · Cited by 37
Bipolar disorder How far are we from a rigorous definition and effective management?
Emilien, G., Septien, L., Brisard, C., Corruble, E., & Bourin, M. (2007) · Progress in Neuro-psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2007.03.005 · Cited by 31
Mood‐stabilizers: the archeology of the concept
Harris, M., Chandran, S., Chakraborty, N., & Healy, D. (2003) · Bipolar Disorders · doi:10.1046/j.1399-5618.2003.00069.x · Cited by 32
Aging-Related Issues in Bipolar Disorder: A Health Services Perspective
Sajatovic, M. (2002) · Journal of Geriatric Psychiatry and Neurology · doi:10.1177/089198870201500303 · Cited by 32
Perspectives on the use of anticonvulsants in the treatment of bipolar disorder
Brambilla, P., Barale, F., & Soares, J. C. (2001) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145701002668 · Cited by 38
Effects of Steady‐State Bupropion on the Pharmacokinetics of Lamotrigine in Healthy Subjects
Odishaw, J. L., & Chen, C. (2000) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.20.19.1448.34866 · Cited by 31
Fullerton, C. A., Busch, A. B., & Frank, R. G. (2010) · Medical Care · doi:10.1097/mlr.0b013e3181ca404e · Cited by 35
Thase, M. E., Bowden, C. L., Nashat, M., Eudicone, J. M., Marcus, R. N., McQuade, R. D., & Carlson, B. X. (2012) · International Journal of Psychiatry in Clinical Practice · doi:10.3109/13651501.2011.632680 · Cited by 32
Self-citationRapid-cycling bipolar disorder
Elhaj, O., & Calabrese, J. R. (2005) · Cambridge University Press eBooks · doi:10.1017/cbo9780511544019.004 · Cited by 31
Self-citationPsychopharmakotherapie bipolarer affektiver Erkrankungen
Grunze, H., Walden, J., Dittmann, S., Berger, T., Bergmann, A., Bräunig, P., Dose, M., Emrich, H. M., Gastpar, M., Greil, W., et al. (2002) · Der Nervenarzt · doi:10.1007/s115-002-8142-7 · Cited by 30
The Manic-Depressive Spectrum and Mood Stabilization: Kraepelin’s Ghost
Ghaemi, S. N., & Baldessarini, R. J. (2007) · Psychotherapy and Psychosomatics · doi:10.1159/000097964 · Cited by 30
The Pharmacological Treatment of Bipolar Disorder: The Question of Modern Advances
Hirschowitz, J., Kolevzon, A., & Garakani, A. (2010) · Harvard Review of Psychiatry · doi:10.3109/10673229.2010.507042 · Cited by 33
Lamotrigine: when and where does it act in affective disorders? A systematic review
Amann, B. L., Born, C., Crespo, J. M., Pomarol‐Clotet, E., & McKenna, P. J. (2010) · Journal of Psychopharmacology · doi:10.1177/0269881110376695 · Cited by 30
Dermatological Manifestations of Stress in Normal and Psychiatric Populations
Rodriguez-Vallecillo, E., & Woodbury-Fariña, M. A. (2014) · Psychiatric Clinics of North America · doi:10.1016/j.psc.2014.08.009 · Cited by 36
The role of lamotrigine in the management of bipolar disorder
Ng, F., Hallam, K. T., Lucas, N., & Berk, M. (2007) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.a920 · Cited by 43
Pharmacotherapy of Depression in Pregnancy
Patkar, A. A., Bilal, L., & Masand, P. S. (2004) · Annals of Clinical Psychiatry · doi:10.1080/10401230490453662 · Cited by 32
Unique design issues in clinical trials of patients with bipolar affective disorder
Post, R. M., & Luckenbaugh, D. A. (2002) · Journal of Psychiatric Research · doi:10.1016/s0022-3956(02)00057-2 · Cited by 29
Grunze, H., Langosch, J. M., Schirrmacher, K., Bingmann, D., von Wegerer, J., & Walden, J. (2001) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/s0278-5846(01)00208-1 · Cited by 29
Evidence-based long-term treatment of bipolar II disorder.
Suppes, T. M., & Dennehy, E. B. (2002) · PubMed · Cited by 35
Treatment of Bipolar Depression
Belmaker, R. H. (2007) · New England Journal of Medicine · doi:10.1056/nejme078042 · Cited by 29
The Bipolar Patient with Comorbid Substance Use Disorder: Recognition and Management
Albanese, M. J., & Pies, R. W. (2004) · CNS Drugs · doi:10.2165/00023210-200418090-00004 · Cited by 35
Taiwan consensus of pharmacological treatment for bipolar disorder
Bai, Y., Chang, C.-J., Tsai, S., Chen, Y.-C., Hsiao, M., Li, C., Tu, P., Chang, S., Shen, W. W., & Su, T. (2013) · Journal of the Chinese Medical Association · doi:10.1016/j.jcma.2013.06.013 · Cited by 29
Köhler, S., Gaus, S., & Bschor, T. (2014) · Pharmacopsychiatry · doi:10.1055/s-0033-1364004 · Cited by 29
Quetiapine monotherapy for bipolar depression
Thase, M. (2008) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s1162 · Cited by 34
Frye, C. A. (2006) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.6.7.1061 · Cited by 27
Unmet needs in bipolar depression
Frye, M. A., Gitlin, M. J., & Altshuler, L. L. (2004) · Depression and Anxiety · doi:10.1002/da.20013 · Cited by 28
Efficacy and Safety of Lamotrigine in Pediatric Patients
Messenheimer, J. A. (2002) · Journal of Child Neurology · doi:10.1177/08830738020170021001 · Cited by 28
New medication treatment options for bipolar disorders
Ketter, T. A., Wang, P. W., Nowakowska, C., & Marsh, W. (2004) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.2004.00410.x · Cited by 36
Treatment options for bipolar depression.
Bowden, C. L. (2005) · PubMed · Cited by 30
Self-citationKetter, T. A., Jones, M., & Paulsson, B. (2007) · Journal of Affective Disorders · doi:10.1016/j.jad.2007.02.006 · Cited by 27
Park, M. C., Goldman, M. A., Carpenter, L. L., Price, L. H., & Friehs, G. M. (2007) · Springer eBooks · doi:10.1007/978-3-211-33081-4_46 · Cited by 26
Activation of TREK-1, but Not TREK-2, Channel by Mood Stabilizers
Kim, E., Lee, D., Hong, S.-G., Han, J., & Kang, D. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18112460 · Cited by 26
Dubovsky, S. L. (2018) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1080/17425255.2019.1558206 · Cited by 27
Dysfunctional Attitudes, Attributional Styles, and Phase of Illness in Bipolar Disorder
Reilly-Harrington, N. A., Miklowitz, D. J., Otto, M. W., Frank, E., Wisniewski, S. R., Thase, M. E., & Sachs, G. S. (2008) · Cognitive Therapy and Research · doi:10.1007/s10608-008-9218-6 · Cited by 32
Self-citationRelationship between placebo response rate and clinical trial outcome in bipolar depression
Iovieno, N., Nierenberg, A. A., Parkin, S. R., Kim, D. J. H., Walker, R. S. W., Fava, M., & Papakostas, G. I. (2015) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2015.12.016 · Cited by 27
The psychopharmacologic treatment of depression and anxiety in the context of chronic pain
Verma, S., & Gallagher, R. M. (2002) · Current Pain and Headache Reports · doi:10.1007/s11916-002-0021-x · Cited by 27
Issues in the treatment of bipolar disorder
Kasper, S. F. (2003) · European Neuropsychopharmacology · doi:10.1016/s0924-977x(03)00076-2 · Cited by 29
Rapid cycling bipolar disorder: historical overview and focus on emerging treatments
Mackin, P., & Young, A. H. (2004) · Bipolar Disorders · doi:10.1111/j.1399-5618.2004.00156.x · Cited by 26
Korean medication algorithm for bipolar disorder: Second revision
Shin, Y. C., Min, K. J., Yoon, B.-H., Kim, W. K., Jon, D., Seo, J. S., Woo, Y. S., Lee, J. G., & Bahk, W. (2013) · Asia-Pacific Psychiatry · doi:10.1111/appy.12062 · Cited by 27
The efficacy of lamotrigine in bipolar disorder: A systematic review and meta‐analysis
Haenen, N., Kamperman, A. M., Prodan, A., Nolen, W. A., Boks, M. P., & Wesseloo, R. (2024) · Bipolar Disorders · doi:10.1111/bdi.13452 · Cited by 25
Lamotrigine in the treatment of bipolar disorder
Bhagwagar, Z., & Goodwin, G. M. (2005) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.6.8.1401 · Cited by 26
Metadata
- Authors
- Calabrese, J. R., Bowden, C. L., Sachs, G. S., Ascher, J. A., Monaghan, E., Rudd, G. D., & The Lamictal 602 Study Group
- Affiliations
- Case Western Reserve University (US)
- GlaxoSmithKline (United Kingdom) (GB)
- ORCID
- Calabrese, Joseph R.
- Venue
- The Journal of Clinical Psychiatry
- Publisher
- Physicians Postgraduate Press, Inc
- Published
- 1999-02-15
- Volume
- 60
- Issue
- 2
- Pages
- 79-88
- ISSN
- 0160-6689 (ISSN-L)
- OpenAlex
- W2058120764
- Cited by
- 1,054
- References
- 0
- Citations by year
- 2026: 5 · 2025: 6 · 2024: 15 · 2023: 8 · 2022: 8 · 2021: 7 · 2020: 162 · 2019: 10 · 2018: 13 · 2017: 13 · 2016: 13 · 2015: 18 · 2014: 23 · 2013: 24 · 2012: 34
- FWCI
- 47.99
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Clinical Psychiatry (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Bipolar Disorder and Treatment
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Maternal Mental Health During Pregnancy and Postpartum
- Keywords
- lamotrigine, bipolar I depression, bipolar disorder, antidepressant monotherapy, antiepileptic drugs, major depressive episode, treatment response, adverse events, headache, drug tolerability
- MeSH terms
- Lamotrigine, Adult, Aged, Ambulatory Care, Anticonvulsants, Bipolar Disorder, Depressive Disorder, Dose-Response Relationship, Drug, Double-Blind Method, Drug Administration Schedule, Female, Humans, Male, Middle Aged, Patient Compliance, Placebos, Psychiatric Status Rating Scales, Severity of Illness Index, Triazines, Treatment Outcome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.